This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2014
Title: Fei Wang: Innovator in Therapeutic Applications of miR Technology
Introduction
Fei Wang is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of therapeutic applications, particularly in the use of microRNAs (miRs) for treating various medical conditions. With a total of 2 patents, his work focuses on innovative methods to address critical health issues.
Latest Patents
Fei Wang's latest patents include advancements related to miR 204 and miR 211, along with their anti-miRs. These patents detail methods for preventing or treating detrimental epithelial cell proliferation, loss of epithelial cell differentiation, age-related macular degeneration, and proliferative vitreal retinopathy. The inventions propose administering effective amounts of miR 204, miR 211, or a mixture of both to individuals in need. Additionally, the patents outline methods for facilitating the transport of substances across epithelial barriers using anti-miR 204 and anti-miR 211. The inventions also encompass pharmaceutical compositions of these miRs and their anti-miRs.
Career Highlights
Fei Wang is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing therapeutic strategies that leverage the unique properties of microRNAs. His innovative approaches have the potential to significantly impact the treatment of various epithelial-related conditions.
Collaborations
Fei Wang has collaborated with notable colleagues, including Sheldon S Miller and Congxiao Zhang. These partnerships have contributed to the development and refinement of his innovative therapeutic methods.
Conclusion
Fei Wang's contributions to the field of microRNA technology exemplify the potential of innovative approaches in medicine. His patents reflect a commitment to addressing significant health challenges through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile